Published in Maedica (Buchar) on January 01, 2012
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn (1957) 7.27
Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J (1973) 6.93
Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax (1992) 6.28
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65
Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis (1991) 2.95
Predicted values for clinical exercise testing. Am Rev Respir Dis (1984) 2.58
The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest (1995) 2.53
Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest (2009) 2.22
Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2010) 1.83
Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.52
Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J (2002) 1.32
The critical power concept. A review. Sports Med (1993) 1.29
Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest (2002) 1.23
Maximum intensity exercise training in patients with chronic obstructive pulmonary disease. Chest (1991) 1.13
Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J (1996) 1.05
Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med (2000) 1.01
A comparison of heart rate methods for predicting endurance training intensity. Med Sci Sports (1975) 0.96
A longitudinal assessment of anaerobic threshold and distance-running performance. Med Sci Sports Exerc (1984) 0.94
Relationship between field walking tests and incremental cycle ergometry in COPD. Respirology (2008) 0.94
Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2008) 0.94
Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest (1996) 0.92
Oxygen consumption, shuttle walking test and the evaluation of lung resection. Respiration (2009) 0.87
Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. Am J Respir Crit Care Med (1999) 0.87
Estimation of maximal work rate based on the 6-minute walk test and fat-free mass in chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2010) 0.79
Exercise capacity as a pulmonary rehabilitation outcome. Respiration (2009) 0.79
Estimating peak work rate during incremental cycle ergometry from the 6-minute walk distance: differences between reference equations. Respiration (2010) 0.77
Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog (2007) 4.73
A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A (2006) 1.78
Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains isolated in Laos. Antimicrob Agents Chemother (2004) 1.56
Bronchioloalveolar carcinoma in a young patient: a case report. Arch Bronconeumol (2013) 1.39
Sensitive and rapid detection of Shigella and enteroinvasive Escherichia coli by a loop-mediated isothermal amplification method. FEMS Microbiol Lett (2005) 1.10
Comparative chracterization of Staphylococcus aureus isolates from throats and noses of healthy volunteers. Jpn J Infect Dis (2004) 1.08
Cytotoxins of the human pathogen Aeromonas hydrophila trigger, via the NLRP3 inflammasome, caspase-1 activation in macrophages. Eur J Immunol (2010) 1.02
The incidence of Escherichia coli having pathogenic genes for diarrhea: a study in the People's Democratic Republic of Lao. Jpn J Infect Dis (2003) 1.02
Vibrio parahaemolyticus effector proteins suppress inflammasome activation by interfering with host autophagy signaling. PLoS Pathog (2013) 0.99
Inflammasome activation via intracellular NLRs triggered by bacterial infection. Cell Microbiol (2011) 0.93
Vibrio cholerae SXT element, Laos. Emerg Infect Dis (2005) 0.93
Detection of EspB using reversed passive latex agglutination: application to determination of enteropathogenic Escherichia coli. Diagn Microbiol Infect Dis (2002) 0.89
Detection and characterization of Shiga toxin-producing Escherichia coli in captive non-domestic mammals. Vet Microbiol (2006) 0.85
Lose the battle to win the war: bacterial strategies for evading host inflammasome activation. Trends Microbiol (2013) 0.85
The bronchoalveolar lavage pattern in radiation pneumonitis secondary to radiotherapy for breast cancer. Maedica (Buchar) (2010) 0.85
Development of a rapid immunochromatographic test to identify enteropathogenic and enterohemorrhagic Escherichia coli by detecting EspB. Diagn Microbiol Infect Dis (2006) 0.84
Aerolysin is activated by metalloprotease in Aeromonas veronii biovar sobria. J Med Microbiol (2004) 0.84
High-temperature protein G is an essential virulence factor of Leptospira interrogans. Infect Immun (2013) 0.83
[Therapeutical approach in severe exacerbation of COPD associating obstructive sleep apnoea and obesity]. Pneumologia (2012) 0.81
The relationship between O-antigens and pathogenic genes of diarrhea-associated Escherichia coli. Jpn J Infect Dis (2005) 0.80
Enteroaggregative Escherichia coli: incidence in Japan and usefulness of the clump-formation test. J Infect Chemother (2002) 0.80
Oxalate-degrading Providencia rettgeri isolated from human stools. Int J Urol (2005) 0.79
Purification and characterization of a novel metalloprotease isolated from Aeromonas caviae. FEMS Microbiol Lett (2004) 0.79
Paraneoplastic syndromes: the way to an early diagnosis of lung cancer. Pneumologia (2015) 0.79
[Evidences related to pulmonary rehabilitation in the respiratory pathology]. Pneumologia (2014) 0.78
Detergents enhance EspB secretion from Escherichia coli strains harboring the locus for the enterocyte effacement (LEE) gene. FEMS Microbiol Lett (2010) 0.77
Clinical characteristics of obese patients with hypertension and chronic ischemic heart disease. Rom J Intern Med (2015) 0.75
Unilateral pulmonary hilar tumor mass: is it always lung cancer? Maedica (Buchar) (2013) 0.75
Sarcoidosis and Aspergillosis: case presentation. Pneumologia (2016) 0.75
Short report: isolation of Escherichia coli O157:H7 from fecal samples of cows in Vietnam. Am J Trop Med Hyg (2005) 0.75
[Iatrogenic tracheal stenosis in patients with COPD: a medico-surgical challenge]. Pneumologia (2013) 0.75
Molecular analysis of VcfQ protein involved in Vibrio cholerae type IV pilus biogenesis. J Med Microbiol (2003) 0.75
Skin, ear and testis--unusual sites of tuberculosis. Pneumologia (2016) 0.75
Polyurethane Microstructures--a Good or Bad in vitro Partner for the Isoflavone Genistein? Nat Prod Commun (2015) 0.75